• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bio-Path Holdings (NQ: BPTH )

    0.8840 +0.0140 (+1.61%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Bio-Path Holdings

    < Previous 1 2 3 4 5 6 7 Next >
    Bio-Path Releases Early Cut Data From Mid-Stage Prexigebersen Trial In Acute Myeloid Leukemia
    Bio-Path Holdings Inc (NASDAQ: BPTH) reported interim data from Stage 2 of the company's Phase 2 study of prexigebersen in combination with decitabine and venetoclax for  
    Via Benzinga
    Bio-Path Holdings Announces Positive Results from Interim Analysis of Phase 2 Clinical Trial of Prexigebersen in Acute Myeloid Leukemia
    From Bio-Path Holdings, Inc.
    Via GlobeNewswire
    Stocks That Hit 52-Week Lows On Tuesday
      On Tuesday, 56 companies set new 52-week lows. 
    Via Benzinga
    Bio-Path Holdings Earnings Preview
    Via Benzinga
    A Preview Of Bio-Path Holdings's Earnings
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
      Wednesday saw 59 companies set new 52-week lows. 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Bio-Path Holdings Announces Successful Completion of First Dose Cohort in Phase 1/1b Clinical Trial of BP1001-A in Solid Tumors
    Advancing to Second Cohort of Phase 1/1b Clinical Trial Evaluating BP1001-A to Treat Patients with Solid Tumors, Including Ovarian, Endometrial, Pancreatic and Breast Cancer 
    From Bio-Path Holdings, Inc.
    Via GlobeNewswire
    Stocks That Hit 52-Week Lows On Monday
      On Monday morning, 70 companies achieved new lows for the year. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular... 
    Via Benzinga
    Why Is FibroGen (FGEN) Stock Down 81% Today?
    FibroGen (FGEN) stock is heading lower on Monday after the company's Phase 3 clinical trial failed to meet its primary endpoint. 
    Via InvestorPlace
    Why Is MoonLake Immunotherapeutics (MLTX) Stock Up 93% Today?
    MoonLake Immunotherapeutics (MLTX) stock is taking off on Monday after reporting positive results from a Phase 2 clinical trial. 
    Via InvestorPlace
    Why Is Bio-Path (BPTH) Stock Down 12% Today?
    Bio-Path (BPTH) stock is sliding lower on Monday after the biotechnology company announced a proposed public share offering. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    It's time to start off the week right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! 
    Via InvestorPlace
    Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 23
    Dallas, Texas--(Newsfile Corp. - June 2, 2023) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate... 
    Via Newsfile
    Earnings Scheduled For May 12, 2023
    Companies Reporting Before The Bell • Honda Motor Co (NYSE:HMC) is expected to report earnings for its fourth quarter. 
    Via Benzinga
    Bio-Path Holdings Reports First Quarter 2023 Financial Results
    Conference Call to be Held Today at 8:30 A.M. ET 
    From Bio-Path Holdings, Inc.
    Via GlobeNewswire
    Bio-Path Holdings to Announce First Quarter 2023 Financial Results on May 12, 2023
    From Bio-Path Holdings, Inc.
    Via GlobeNewswire
    Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q4 '22
    Dallas, Texas--(Newsfile Corp. - April 10, 2023) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): The... 
    Via Newsfile
    Bio-Path Holdings Reports Full Year 2022 Financial Results
    Conference Call to be Held Today at 8:30 A.M. ET 
    From Bio-Path Holdings, Inc.
    Via GlobeNewswire
    Bio-Path Holdings to Announce Fourth Quarter and Full Year 2022 Financial Results on March 31, 2023
    From Bio-Path Holdings, Inc.
    Via GlobeNewswire
    Bio-Path Holdings Provides Clinical and Operational Update
    Company Expects to Achieve Several Near-Term Clinical Milestones 
    From Bio-Path Holdings, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q3 '22
    Dallas, Texas--(Newsfile Corp. - December 19, 2022) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners updates coverage on Bio-Path... 
    Via Newsfile
    Bio-Path Holdings Announces First Patient Dosed in Phase 1/1b Clinical Trial of BP1001-A in Solid Tumors
    Phase 1/1b Clinical Trial Evaluating Ability of BP1001-A to Treat Patients with Solid Tumors, Including Ovarian, Endometrial, Pancreatic and Breast Cancer 
    From Bio-Path Holdings, Inc.
    Via GlobeNewswire
    Bio-Path Holdings Q3 2022 Earnings Conference Call On November 15, 2022 At 08:30 AM ET
    Bio-Path Holdings (NASDAQ:BPTH) will host a conference call at 08:30 AM ET on November 15, 2022, to discuss Q3 2022 earnings results. How to Attend Bio-Path Holdings (BPTH) Conference Call Follow this... 
    Via Benzinga
    Analyzing Bio-Path Holdings's Short Interest
    Bio-Path Holdings's (NASDAQ:BPTH) short percent of float has fallen 10.42% since its last report. The company recently reported that it has 34 thousand shares sold short, which is 0.43% of all regular... 
    Via Benzinga
    Bio-Path Holdings Reports Third Quarter 2022 Financial Results
    Conference Call to be Held Today at 8:30 A.M. ET 
    From Bio-Path Holdings, Inc.
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.